Robert Donald Harvey

30PUBLICATIONS
126CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jan 08, 2026
From Biology to Bedside: Challenges and Strategies in Developing Combination Cancer Therapies in Early-Phase Trials.

Niamh Coleman, R Donald Harvey, David S Hong

|Dec 16, 2025
Estimated Glomerular Filtration Rate Equations Overestimate Renal Function Compared With Measured Glomerular Filtration Rate Using 24-Hour Urine Creatinine Clearance.

Reza Lahiji, Ernest Allen Morton, Lorenzo Storino Ramacciotti

|Jul 24, 2025
Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology.

Laura A Levit, Mirat Shah, Mark J Ratain

|Jul 01, 2025
Who Reconstitutes the Chemotherapy? The Educational and Practice Needs of Oncology Pharmacists in West Africa: A Call for Multidisciplinary Team Approach in Oncology Care.

Runcie C W Chidebe, Ramatu M Alabelewe, Krishna Prasad Sapkota

|Jul 30, 2024
Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement.

Ramya Thota, Patricia A Hurley, Therica M Miller

|Nov 20, 2023
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.

Benedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam

Pageof 5

Frequent Collaborators

4 joint publications

Mehmet Asim Bilen

4 joint publications

Suanna S Bruinooge

4 joint publications

Caroline Schenkel

3 joint publications

Elizabeth Garrett-Mayer